Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle

Phase 2 Unknown 33 enrolled Gustave Roussy, Cancer Campus, Grand Paris

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study looks at isolated pelvic perfusion and limbs' girdle with 1 mg tumor necrosis factor alpha (TNFa) in the treatment of locally advanced sarcoma of the pelvis and limbs' girdle.

Timeline

Start: 2004-05
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Melphalan	Small molecule	—	—
Subject	TASONERMIN	Protein / enzyme biologic	1 mg	—

Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle

Summary

Timeline

Drugs

Indications